dc.creatorGelman, Diego Matias
dc.creatorNoain, Daniela Maria Clara
dc.creatorAvale, Maria Elena
dc.creatorOtero Corchon, Veronica
dc.creatorLow, Malcolm J.
dc.creatorRubinstein, Marcelo
dc.date.accessioned2019-07-16T20:52:04Z
dc.date.accessioned2022-10-14T22:35:00Z
dc.date.available2019-07-16T20:52:04Z
dc.date.available2022-10-14T22:35:00Z
dc.date.created2019-07-16T20:52:04Z
dc.date.issued2003-08
dc.identifierGelman, Diego Matias; Noain, Daniela Maria Clara; Avale, Maria Elena; Otero Corchon, Veronica; Low, Malcolm J.; et al.; Transgenic mice engineered to target Cre/LoxP-mediated DNA recombination into catecholaminergic neurons; Wiley-liss, Div John Wiley & Sons Inc; Genesis; 36; 4; 8-2003; 196-202
dc.identifier1526-954X
dc.identifierhttp://hdl.handle.net/11336/79707
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4314641
dc.description.abstractTo introduce restricted DNA recombination events into catecholaminergic neurons using the Cre/loxP technology, we generated transgenic mice carrying the Cre recombinase gene driven by a 9 kb rat tyrosine hydroxylase (TH) promoter. Immunohistochemistry performed on transgenic mouse brain sections revealed a high number of cells expressing Cre in areas where TH is normally expressed, including the olfactory bulb, hypothalamic and midbrain dopaminergic neurons, and the locus coeruleus. Double immunohistochemistry and immunofluorescence indicated that colocalization of TH and Cre is greater than 80%. Cre expression was also found in TH-positive amacrine neurons of the retina, chromaffin cells of the adrenal medulla, and sympathetic ganglia. We intercrossed TH-Cre mice with the floxed reporter strain Z/AP and observed efficient Cre-mediated recombination in all areas expressing TH, indicating that transgenic Cre is functional. Therefore, we have generated a valuable transgenic mouse strain to induce specific mutations of "floxed" genes in catecholaminergic neurons.
dc.languageeng
dc.publisherWiley-liss, Div John Wiley & Sons Inc
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pubmed/12929090
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/gene.10217
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1002/gene.10217
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectCATECHOLAMINE
dc.subjectCRE RECOMBINASE
dc.subjectDOPAMINE
dc.subjectLOXP
dc.subjectNOREPINEPHRINE
dc.subjectTRANSGENIC MOUSE
dc.subjectTYROSINE HYDROXYLASE
dc.titleTransgenic mice engineered to target Cre/LoxP-mediated DNA recombination into catecholaminergic neurons
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución